TuHURA Biosciences, Inc./NV HURA US Equity☆

TuHURA Biosciences, Inc./NV (Nasdaq: HURA), an SEC filer in Pharmaceutical Preparations, closed at $2.11, -0.9%, on 2026-08-28, with a market cap of $134M and a return on equity of -169.2%. Institutional ownership, earnings history, filed financials and clinical trials are on the tabs below.